Hep Email Update European Medicines Agency Approves First AI Tool for Fatty Liver Disease Trials The AI-assisted pathology assessment tool will help trial pathologists determine MASH severity from liver biopsies. Addressing Treatment Gap for People With HIV and Hepatitis C People living with both HIV and hepatitis C can benefit from direct-acting antivirals, but many are not receiving treatment. Current, Former CDC Staff Warn Against Slashing Support to Local Public Health Departments City and state health agencies need the collaboration of CDC experts to help investigate disease outbreaks and other threats to public health. Advertisement Closing the Hepatitis C Treatment Gap Here’s why so few Americans have been cured of hep C—and how we can do better. How to Get Hepatitis C Treatment Tips for people with hep C and for providers. Hepatitis C Survey Tell us about your experience with hepatitis C. What Is Hepatitis C? Get the basics! Science News Fatty Liver Disease Is Expected to Skyrocket By 2050 TACE-Based Treatment Combinations Effective Against Intermediate-Stage Liver Cancer Improving Gene Editing in the Liver Half of Medicaid Beneficiaries With Hep C Had at Least One Comorbidity Newsfeed European Medicines Agency Approves First AI Tool for Fatty Liver Disease Trials Trump White House Terminates Hundreds of Research Grants, Many on HIV and Minorities Florida Doctor's License Restricted After Hep C Cases Linked to Clinic AI Tool Boosts Enrollment in Clinical Trials Science News Fatty Liver Disease Is Expected to Skyrocket By 2050 TACE-Based Treatment Combinations Effective Against Intermediate-Stage Liver Cancer Improving Gene Editing in the Liver Half of Medicaid Beneficiaries With Hep C Had at Least One Comorbidity Newsfeed European Medicines Agency Approves First AI Tool for Fatty Liver Disease Trials Trump White House Terminates Hundreds of Research Grants, Many on HIV and Minorities Florida Doctor's License Restricted After Hep C Cases Linked to Clinic AI Tool Boosts Enrollment in Clinical Trials

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to [email protected] by [email protected]. Please remember to add [email protected] to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: